Abstract. BACKGROUND: Accumulating evidences have shown that long non-coding RNAs (lncRNAs), longer than 200 nucleotides in length, play a crucial role in cancer occurrence and development. However, the relationships between most lncRNAs and gastric carcinogenesis remain poorly understood. OBJECTIVE: To explore the diagnostic value of one typical lncRNA, long intergenic non-protein coding RNA 1006 (LINC01006), in gastric cancer. METHODS: First, real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to determine the expression levels of LINC01006 in various gastric tissues from gastric cancer patients, healthy controls, and gastric dysplasia. Next, the correlation between LINC01006 expression levels and clinicopathological features of patients with gastric cancer was assessed. Finally, the relative levels of LINC01006 in gastric cancer cell lines comparing to normal gastric epithelial cell line was analyzed. RESULTS: LINC01006 levels in cancer tissues were significantly lower than those in adjacent normal tissues (P < 0.001) and healthy control tissues (P < 0.001). Its expression was associated with age (P = 0.013), tumor location (P = 0.022), tumor size (P = 0.030), and venous invasion (P = 0.018). Moreover, expression of LINC01006 was downregulated in two gastric cancer cell lines, MGC-803 (P < 0.05) and AGS (P < 0.001) compared to normal gastric epithelial cell line GES-1. CONCLUSIONS: All the data implied that LINC01006 may be a novel biomarker for gastric cancer.
Introduction 1
Among global malignancies, gastric cancer is the 2 second leading cause of cancer death annually [1, 2] .
3
The high morbidity is partially attributed to delayed di-However, existing conventional diagnostic methods are 10 largely limited in sensitivity and specificity. There-11 fore, discovering novel biomarkers for gastric cancer 12 detection at early period has become a hotspot and 13 gained increasing attention among scholars. Long non-14 coding RNAs (lncRNAs) is one type of new potential 15 biomarkers [5, 6] .
16
LncRNAs are a new category of transcripts with a 17 length greater than 200 nucleotides [7] . On the basis 18 of genomic localization, they can be classified roughly 19 into six broad categories: sense, antisense, intronic, in-20 tergenic, enhancer, and bidirectional lncRNAs [7, 8] . 21 Despite lack of protein-encoding potential, they play 22 essential roles in a variety of biological processes, such 23 as cell cycle, proliferation, apoptosis, and invasion. 24 Also, lncRNAs have multiple regulatory functions in 25 gene expression and chromatin remodeling [9] [10] [11] . 26 Previous studies demonstrated that many lncRNAs 27 were functionally associated with carcinogenesis. were both proved to be downregulated in gastric can-39 cer [15, 16] . However, the correlation between most 40 lncRNAs and gastric cancer is largely unknown.
41
In this study, we focused on long intergenic non- We quantified LINC01006 expression levels in gas-165 tric cancer tissues by qRT-PCR. We observed that 166 LINC01006 levels in tumor tissues collected from gas-167 tric cancer patients were significantly lower than those 168 in their corresponding adjacent normal tissues (P < 169 0.001, Fig. 1 ). Then, we measured the expression lev-170 els of LINC01006 in gastric tissues at three differ-171 ent stages of tumorigenesis. As shown in Fig. 2 , com-172 pared with healthy controls, the expression levels of 173 LINC01006 were significantly decreased in dysplastic 174 (P < 0.001) and gastric cancer group (P < 0.001).
175
A receiver operating characteristic (ROC) curve was 176 performed to test whether LINC01006 had value in 177 clinical diagnosis of gastric cancer. The area under the 178 curve (AUC) was up to 0.748 (95% confidence inter-179 val 0.671-0.826; P < 0.001; Fig. 3) , with the opti-180 mal cut-off value of 11.625. The sensitivity and speci-181 ficity were 69.2% and 75.6%, respectively. These sug-182 gest that LINC01006 has the potential to be a reliable 183 biomarker in gastric cancer screening.
184
Statistical power of these results was then calcu-185 lated by GPower 3.1 with α set to 0.05. For LINC1006 186 levels in gastric cancer tissues and their adjacent nor-187 mal tissues, the statistical power (1 − β) was 1. For 188 LINC01006 levels in gastric tissues at three different 189 stages of tumorigenesis, the statistical power (1 − β) 190 was also 1. These meant that with the number of sam-191 ples in this study, we could make a correct decision 192 by obtaining a significant result with a high probability 193 (1 − β). Previous studies demonstrated that gastric cancer 197 was distinguishable between males and females as well 198 as between older and younger individuals [21] . In the 199 current study, we observed significant differences un-200 der 60 years old and above (P = 0.013, Table 1 ). How-201 ever, no significant differences were found between 202 males and females (Table 1) . [30] . HOTAIR has been ob-253 served in gastric cancer. Its role in gastric cancer re-254 sembles H19, promoting cell proliferation, invasive-255 ness, and metastasis but inhibiting apoptosis [31] .
256
The purpose of the current study was to investigate 257 the clinical value of LINC01006 in gastric cancer. We 258 observed significantly decreased LINC01006 expres-259 sion levels in gastric cancer tissues compared to those 260 of adjacent non-tumorous tissues (Fig. 1) , which is in 261 line with lncRNA microarray screening [17] . Besides, 262 we found that LINC01006 levels varied from healthy 263 to gastric cancer group. The LINC01006 levels were 264 adversely associated with tumor stage; the more ad-265 vanced the tumor was, the lower the expression levels 266 were (Fig. 2) . Additionally, compared with normal gas-267 tric epithelial cell line (GES-1), LINC01006 was sig-268 nificantly downexpressed in gastric cancer cell lines, 269 MGC-803 and AGS (Fig. 4) . The reduction was more 270 remarkable between GES-1 and AGS (Fig. 4) . More-271 over, the statistical power was high enough for us to 272 make the correct decision. LINC1006 was downregu-273 lated in gastric cancer tissues and further decreased in 274 more advanced tumors. These revealed that LINC1006 275 might function as a tumor suppressor gene in the gas-276 tric cancer progression. All of these results implied that 277 LINC01006 possibly played a crucial part in occur-278 rence and development of gastric cancer and may be a 279 good biomarker for gastric cancer.
280
Biomarkers are predominantly classified into four 281 types, diagnostic, prognostic, predictive and therapeu-282 tic biomarkers [32, 33] . An ideal diagnostic biomarker 283 should be a noninvasive marker to detect diseases at 284 early stages. A prognostic biomarker provides assess-285 ment or prediction of the possible course of diseases, 286 chances of recovery or survival from the disease, and 287 thus yields valuable advice for further therapies. A pre-288 dictive biomarker is utilized to identify whether sub-289 populations of patients respond to an aimed therapy or 290 not. A therapeutic biomarker is usually a potential tar-291 get protein for cancer therapy [32, 33] . from healthy controls with an AUC of 0.748 (Fig. 3) .
317
The sensitivity and specificity were 69.2% and 75.6%, 318 respectively, both higher than those of CEA and CA19- (Table 1) . However, our results showed that the 366 proximally located gastric cancer (cardia) had higher 367 LINC1006 levels than corpora ventriculi and sinuses 368 ventriculi (Table 1) . Venous invasion, associated with 369 invasion depth, metastasis, tumor size, tumor location 370 and growth pattern, was reported to be the indepen-371 dent prognostic factors of gastric cancer. Gastric pa-372 tients undergoing extramural venous invasion had sig-373 nificantly lower 1-year survival rate than those with-374 out [46] . However, in this study, gastric cancer with 375 venous invasion had higher LINC1006 level (Table 1) . 376 Those inconsistencies may be partially due to the small 377 number of samples. Thus, more investigations into its 378 prognostic significance are required.
379
Limitations of our study should be acknowledged. 380 Firstly, compared to studies recruiting thousands of 381 gastric cancer cases and controls [47], our number 382 was smaller. With more cases, our data would be 383 more convinced. Secondly, since that we failed to col-384 lect data before and after gastrectomy, we failed to 385 monitor the dynamic changes of gastric cancer. Fi-386 nally, lncRNAs have been identified not only within 387 cells, but also in biological fluids, including blood, 388 urine and saliva. There are abundant lncRNAs in hu-389 man blood [9, 10, 32] . However, we only focused on 390 LINC1006 in gastric cancer tissues. 
